Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is a once in a lifetime opportunity here!
Canada practically is federally legalized!
This is a Canadian mmj play at the ground level.
I'm willing to sell at .20s. Till then accumulation.
Sprwf buy now or be sorry later!
News may come tomorrow. I hope it does!
Based off the pr the company will release news prior to any halt on news. So you have to be ready here.
Management update 4/1/2014.
CALGARY, ALBERTA--(Marketwired - April 1, 2014) - Supreme Pharmaceuticals Inc. (the "Company") (OTCBB:SPRWF)(TSX VENTURE:SL) advises that management is currently visiting the producing medical marijuana facility on which the Company may acquire an option to purchase, as part of its due diligence. The facility is located in the south Okanagan and the Company will get an onsite evaluation of the complex as it enters the final stages of the due diligence period. The 10 day due diligence period expires as of Friday April 4th, 2014. There is no assurance that the normal due diligence and other conditions will be met successfully and the option acquired. The Company will provide further updates as this matter progresses.
The Company has signed a conditional agreement with an arms-length South Okanagan-based company, whereby the Company may acquire an option to purchase its producing medical marijuana business until March 23, 2015 for the sum of $1,000,000, payable in cash and shares, subject to regulatory approval. The Company is currently in a 10-business day due diligence period and if satisfied, Supreme will, subject to prior approval of the TSXV, make a $100,000 option payment.
President and CEO, David Stadnyk stated: "We are looking forward to visit the facility and move this process along."
SUPREME PHARMACEUTICALS INC.
David Stadnyk, President & CEO
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FORWARD LOOKING INFORMATION
This News Release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com. This News Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Supreme Pharmaceuticals Inc.
David Stadnyk
President & CEO
(647) 340-6744
info@supremepharmaceuticals.com
www.supremepharmaceuticals.com
Read more at http://www.stockhouse.com/news/press-releases/2014/04/01/supreme-pharmaceuticals-inc-executive-management-visits-producing-facility-as#2r40a3Wr7A8ampvq.99
Attbf is the big brother of sprwf. Sprwf will be rising soon!
I've never felt so strongly for a company at the ground level to see this one grow. $-$
People have been given almost 2 trading weeks to buy tickets to the game. Once this is sold out you know you will be paying a premium here.
The intentions of sprwf to acquire a mmj cultivator is for a commercial license.
Mm has set a price restriction of .05-.06 till news hits. Once news hit this will be the runner of a life time!
This is screaming buy!!! Mm is selling tickets to the sprwf show!!! Get ready for the ride of your life!!
Once news comes .20 will be the new floor.
If you missed out on phot, trtc, grnh, etc. don't miss out on one of the first legitimate Canadian mmj companies!
Sprwf will be the supreme mmj stock in Canada and United States!
Management will gain the confidence of all the mmj sector once news comes.
There are other penny plays with outstanding of over 2 to 3 billion or more. This is highly undervalued.
This market cap of less then 7 million? And were pretty much assured to get a mmj cultivator soon! A gift!
Sprwf catalysts included acquisition, private placement completion, and medical device development(vape)
We have traded over 200 million in total volume in Canada and the United States since the new company.
Mm has put up this wall and will fall down with news.
.05 ground floor prices it's unbelievable!
This has similar share structure to trtc and cbgi. Both are in cultivation. Sprwf is going into cultivation. Pps undervalued.
.10 will look cheap once we get the good news!
This will instantly become a front runner upon news release by eow.
Once news hits everyone will have to slap the ask to get in.
Shorts will lose big time here more for my pocket.
4/4/2014 a day to watch this stock it is smart to get in the 5s.
The news that will be coming shortly. Before April 4th.
That is almost 9% of the company.
Insiders own almost 15 million shares out of 128 million
This is a long term hold.
Sprwf interviewed on huff post!
http://m.huffpost.com/ca/entry/5062688
Outstanding shares 128million.
RSI is in the 50s seriously under bought.
We will see big news shortly.
These guys aren't your typical penny players with shady backgrounds. These guys got it together and will ensure the success of this company in the mmj arena.
Currently on the supreme umbrella of leadership.
http://supremepharmaceuticals.com/index.php/corporate/directors-bios
David Stadnyk, President and CEO
Mr. David Stadnyk is the President and CEO of Supreme Pharmaceuticals Inc. Mr. Stadnyk is the Founder of Stadnyk and Partners. Mr. Stadnyk has has extensive knowledge in the public capital markets and strong relationships with global investment banks and independent boutique investment dealers. Mr. Stadnyk has provided a variety of leadership, investment and developmental roles in the biotech and pharmaceuticals sector and resource sector. He has more than 25 years of investment banking experience and he has successfully pioneered equity capital fundraising efforts in excess of well over $500 MM. Mr. Stadnyk is the President and CEO of First Sahara Energy. Mr. Stadnyk is also the Chairman of Stadnyk Foundation Inc., a sport philanthropic organization. Mr. Stadnyk was Co-Founder of Praxis Pharmaceuticals Inc. now Pharmaxis Pharmaceuticals Inc. and Co-Founder of Eupraxia Pharmaceuticals Inc. Mr. Stadnyk was President and Founder of Starlight Sports and Entertainment Inc., founder of the TEAM 1040 AM Sports Radio Station, owned the Vancouver 86ers/Whitecaps Inc., founder of the Vancouver Angels/Breakers, Vancouver's first Women's professional soccer team, and founder of the Vancouver Ravens Lacrosse team. From 1998 to 2006, Mr. Stadnyk was the President of Patch International Inc., an international junior oil and gas exploration and production company. Mr. Stadnyk was a Director of Birch Lake Energy Inc., Canadian Energy Exploration Inc., President and Ceo of Guerrero Exploration Inc. and Co-Founder and a Director of Arsenal Energy Inc., listed on the TSX Venture Exchange.
George Tsafalas, Director
Mr. George Tsafalas has extensive experience in senior operational management, corporate business development and corporate finance in the private and public sectors. Mr. Tsafalas specializes in the execution of strategic budget plans and monitors the development of the portfolio programs, including review of the financial objectives and milestones. Mr. Tsafalas brings experience in the attraction of private equity capital, including angel investment groups and firms, and has assisted in several successful equity capital fundraising efforts. Mr. Tsafalas has been a Senior Executive, Chief Financial Officer, Executive Member of the Board of Director's and Chair of the Audit Committee of several companies.
Alan Levian, Director
Mr. Levien is an experienced financial executive. As an entrepreneur, Mr. Levien has been involved in a number of successful self-started and managed ventures.
Zach Stadnyk
Zach Stadnyk has a rich history in investor relations, business development, and corporate finance. Mr. Stadnyk has worked with over ten public companies across several different industries in addition to several privately held companies. Mr. Stadnyk specializes in small caps and is a CFA candidate.
Brian D. Keane – Investment Banker
Mr. Brian D. Keane is currently President of Plaza Capital Partners, a North American Venture Capital/Advisory boutique focused on Natural resources/ Oil & Gas and Life Sciences. He has over 13 years of Capital Markets experience specializing in originating, advising, and investing in emerging growth companies in the US, Canada, and Asia. He has structured and invested in over 50 companies and IPO/Reverse mergers totaling over $1.5 Billion across every major industry. Since 2002, he has advised and help manage several investment funds that include: Paragon Capital, LP 2009-2011; Keating Capital (NASDAQ:KIPO) & Four Springs Capital 2008-2009; PIPE Investment Fund 2002-2008. Previously, Brian worked at several investment banks that include: Rodman & Renshaw, LLC, focused on capital raising/advisory services for Oil & Gas/life science and biotechnology companies. He was an associate at Ladenburg Thalmann & Co. and Techvest LLC (acquired by Rodman). After working at several law firms, Brian began his career on Wall Street as an equity trader for National Discount Brokers Group, NYSE:NDB (acquired by Deutsche Bank) He earned a BS from the University of Scranton 1997 and a JD from New York Law School 2000. He is licensed Series 7,63,79 with the Financial Industry Regulatory Authority.